FINWIRES · TerminalLIVE
FINWIRES

Nvidia Poised to Report Fiscal Q2 Beat, Wedbush Says

By

Nvidia (NVDA) is set to beat its fiscal Q2 guidance and provide a stronger-than-expected outlook for October, Wedbush Securities said in a note Monday.

The company is scheduled to report the results on Wednesday.

Fiscal Q2 guidance was $91 billion in revenue and about 75% gross margin, implying earnings per share of about $2.03, according to the note. Wedbush forecasts $91 billion in revenue and $2.05 EPS, compared with consensus of $92 billion and $2.09.

The key question is whether another strong earnings result will earn a reaction, the firm said, noting that Nvidia has beaten expectations in each of the past three quarters, but the stock is roughly unchanged from October last year.

The firm said the company's stronger outlook should be supported by solid hyperscaler spending and "a supply position we continue to view as the best in the industry at a point where component and material access, not end demand, is defining shipments."

Wedbush reiterated its outperform rating and $330 price target on Nvidia.

Price: $209.21, Change: $-5.51, Percent Change: -2.57%

Related Articles

Wire

Update: Regal Partners H1 Normalized Earnings, Revenue Up; Shares Fall 7%

(Updates to add stock movement in the headline and the last paragraph)Regal Partners (ASX:RPL) logged AU$0.214 in normalized EPS for the first half, compared with AU$0.105 a year ago, a Monday filing showed.For the six months ended June 30, income from ordinary activities was AU$226.4 million versus AU$128.7 million previously, the Australia-listed alternative investment manager company added.The board declared an interim dividend of AU$0.12 per share, up from AU$0.06 a year earlier, payable Sept. 30 to shareholders on record as of Aug. 31.The company's shares fell around 7% in recent Monday trade.

ASX:RPL
Wire

Philip Morris Reports FDA Authorization for ZYN ULTRA Nicotine Pouches

Philip Morris International (PM) said Friday it has obtained authorization from the US Food and Drug Administration for the marketing of 11 ZYN ULTRA moist oral nicotine pouch products.The firm said the FDA issued Marketing Granted Orders to its US affiliate, Swedish Match USA. Additional 11mg variants are still under scientific review, it added.The authorizations add selection of ZYN ULTRA products to its portfolio of alternatives for adults who smoke or use traditional oral tobacco products, the company said.Price: $188.44, Change: $-3.08, Percent Change: -1.61%

$PM
Wire

Top Cryptocurrencies Jump; Bitcoin Tops $77,000

Major digital assets jumped Friday, with Bitcoin (BTC-USD) topping $77,000.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 6.4% in the past 24 hours. The Nasdaq 100 and the S&P 500 each gained 0.5%, and the Dow Jones Industrial Average increased 0.8.%.Bitcoin gained 6.1% to $77,122, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose 16% to $71.1 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, rose 3.6% to $2,414.XRP (XRP-USD) surged 11%, BNB (BNB-USD) increased 3.7%, and Solana (SOL-USD) added 4%. Dogecoin (DOGE-USD) rose 5.7%, while Cardano (ADA-USD) jumped 11%.The total market value of the cryptocurrency industry rose 5.1% in the past 24 hours to $2.59 trillion, with trading volume gaining 9.2% to $161.4 billion.Price: $77126.61, Change: $+4113.61, Percent Change: +5.63%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD